Mckinley Capital Management LLC Astrazeneca PLC Transaction History

Mckinley Capital Management LLC

$558 Million
Q2 2024

A detailed history of Mckinley Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mckinley Capital Management LLC holds 14,825 shares of AZN stock, worth $987,789. This represents 0.21% of its overall portfolio holdings.

Number of Shares

14,825

Previous 16,171 8.32%

Holding current value

$987,789

Previous $1.1 Million 5.57%

% of portfolio

0.21%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $89,926 - $108,797	-1,346 Reduced 8.32%	14,825 $1.16 Million
Q1 2024 May 01, 2024	SELL	$61.03 - $69.57 $592,357 - $675,246	-9,706 Reduced 37.51%	16,171 $1.1 Million
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $1.13 Million - $1.26 Million	-18,185 Reduced 41.27%	25,877 $1.74 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $247,791 - $273,965	-3,821 Reduced 7.98%	44,062 $2.98 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $36,003 - $39,042	-515 Reduced 1.06%	47,883 $3.43 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $62,897 - $71,313	-996 Reduced 2.02%	48,398 $3.36 Million
Q4 2022 Jan 18, 2023	SELL	$54.21 - $70.44 $4,662 - $6,057	-86 Reduced 0.17%	49,394 $0
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $386,621 - $989,889	7,292 Added 17.28%	49,480 $2.71 Million
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $16,889 - $20,274	-285 Reduced 0.67%	42,188 $2.79 Million
Q1 2022 Apr 29, 2022	SELL	$55.72 - $67.12 $44,743 - $53,897	-803 Reduced 1.86%	42,473 $2.82 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $41,541 - $49,085	-769 Reduced 1.75%	43,276 $2.52 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $107,564 - $117,689	-1,936 Reduced 4.21%	44,045 $2.65 Million
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $22,370 - $27,803	-462 Reduced 0.99%	45,981 $2.75 Million
Q1 2021 Apr 21, 2021	SELL	$47.16 - $54.44 $8,677 - $10,016	-184 Reduced 0.39%	46,443 $2.31 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $60,310 - $72,118	-1,243 Reduced 2.6%	46,627 $2.33 Million
Q3 2020 Nov 02, 2020	SELL	$53.07 - $61.1 $134,160 - $154,460	-2,528 Reduced 5.02%	47,870 $2.62 Million
Q2 2020 Jul 27, 2020	SELL	$43.1 - $55.31 $113,137 - $145,188	-2,625 Reduced 4.95%	50,398 $2.67 Million
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $48,938 - $66,472	-1,295 Reduced 2.38%	53,023 $2.37 Million
Q4 2019 Jan 23, 2020	BUY	$42.46 - $50.46 $464,809 - $552,385	10,947 Added 25.24%	54,318 $2.71 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $308,964 - $350,164	-7,701 Reduced 15.08%	43,371 $1.93 Million
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $387,823 - $433,597	-10,403 Reduced 16.92%	51,072 $2.11 Million
Q1 2019 May 02, 2019	BUY	$35.49 - $43.02 $16,999 - $20,606	479 Added 0.79%	61,475 $2.49 Million
Q4 2018 Feb 11, 2019	BUY	$36.86 - $41.49 $321,087 - $361,419	8,711 Added 16.66%	60,996 $2.32 Million
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $1.02 Million - $1.17 Million	29,454 Added 129.01%	52,285 $2.07 Million
Q2 2018 Jul 13, 2018	BUY	$34.55 - $37.05 $45,156 - $48,424	1,307 Added 6.07%	22,831 $801,000
Q1 2018 May 04, 2018	SELL	$32.97 - $36.63 $98,910 - $109,890	-3,000 Reduced 12.23%	21,524 $753,000
Q4 2017 Feb 08, 2018	SELL	$32.09 - $34.78 $866,558 - $939,199	-27,004 Reduced 52.41%	24,524 $851,000
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $843,720 - $990,556	-29,134 Reduced 36.12%	51,528 $1.75 Million
Q2 2017 Aug 14, 2017	BUY	N/A	80,662	80,662 $2.75 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.

Account

Mckinley Capital Management LLC Astrazeneca PLC Transaction History